Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 13, 2015

Total Value ($000): $320,401 (100.0% shares, 0.0% debt)

Holdings (10)

— ABIOMED INC 37.4%

Value ($000) $119,889 Shares 3,150,000 Est. Cost $21.56 Unrealized —

— REVANCE THERAPEUTICS INC 24.3%

Value ($000) $77,789 Shares 4,592,047 Est. Cost $31.50 Unrealized —

— CORIUM INTL INC 17.8%

Value ($000) $57,055 Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENDOLOGIX INC 13.6%

Value ($000) $43,633 Shares 2,514,936 Est. Cost $18.00 Unrealized —

— ZIOPHARM ONCOLOGY INC 4.3%

Value ($000) $13,691 Shares 2,700,408 Est. Cost $1.96 Unrealized —

— ACURA PHARMACEUTICALS INC 1.4%

Value ($000) $4,402 Shares 10,284,886 Est. Cost $1.82 Unrealized —

MNOV MEDICINOVA INC 1.1%

Value ($000) $3,558 Shares 1,170,370 Est. Cost $2.95 Unrealized +14.9%

— CURIS INC 0.1%

Value ($000) $350 Shares 233,797 Est. Cost $3.19 Unrealized —

— ECHO THERAPEUTICS INC 0.0%

Value ($000) $17 Shares 12,319 Est. Cost $2.52 Unrealized —

— PALATIN TECHNOLOGIES INC 0.0%

Value ($000) $17 Shares 23,928 Est. Cost $0.59 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	3,150,000	$119,889	37.4%	$21.56	—	COM	003654100
—	REVANCE THERAPEUTICS INC	4,592,047	$77,789	24.3%	$31.50	—	COM	761330109
—	CORIUM INTL INC	9,353,304	$57,055	17.8%	$7.77	—	COM	21887L107
—	ENDOLOGIX INC	2,514,936	$43,633	13.6%	$18.00	—	COM	29266S106
—	ZIOPHARM ONCOLOGY INC	2,700,408	$13,691	4.3%	$1.96	—	COM	98973P101
—	ACURA PHARMACEUTICALS INC	10,284,886	$4,402	1.4%	$1.82	—	COM NEW	00509L703
MNOV	MEDICINOVA INC	1,170,370	$3,558	1.1%	$2.95	+14.9%	COM NEW	58468P206
—	CURIS INC	233,797	$350	0.1%	$3.19	—	COM	231269101
—	ECHO THERAPEUTICS INC	12,319	$17	0.0%	$2.52	—	COM NEW	27876L206
—	PALATIN TECHNOLOGIES INC	23,928	$17	0.0%	$0.59	—	COM PAR $ .01	696077403